ASSOCIATION OF GLYCOCONJUGA.TES EXPRESSION APjO) CUNICAL SIGNIFICANCE IN HUMAN GASTRIC CANCER

糖复合物表达协会 APjO) 在人类胃癌中的重要意义

基本信息

  • 批准号:
    13671286
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Cell surface glycosylation is dramatically changed during oncogenesis, and is considered to correlate with the malignant potential and development of cancer. Therefore, detection of carbohydrates of tumor tissues with lectins and antibodies against tumor-associated carbohydrate antigens may help to evaluate the metastatic potential and aggressive tumor behavior.In this study, we performed histochemical and biochemical analysis of human gastric cancer tissues using lectins to investigate relationship between sialylation of glycoconjugates and clinicopathological characteristics of the tumor. We describe here that Maackia amurensis leukoagglutinin (MAL)-positive glycoconjugates only appear in gastric tumor tissues. On the other hand, no staining was detected in the non-cancerous region. And the high level expression of MAL-positive staining was significantly frequent in cases of lymph node metastasis, lymphatic vessel invasion, and venous invasion, as well as in cases of advanced tumors. Furthermore, prognosis analysis showed that the high level expression of MAL-positive glycoconjugates is an independent factor in a shorter survival together with the depth of invasion and the venous invasion.In conclusion, the present results indicate that MAL-positive glycoconjugates appear in gastric tumor tissu es and suggest that the abnormal glycosylation detected using MAL closely related to unfavorable behavior of gastric cancer. Therefore, MAL would be an effective tool used to determine the prognosis of patients with gastric cancer.
细胞表面糖基化在肿瘤发生过程中发生显著变化,并且被认为与癌症的恶性潜能和发展相关。因此,检测肿瘤组织中的糖与凝集素和肿瘤相关的糖抗原的抗体可能有助于评估转移潜力和侵袭性肿瘤behavior.In本研究中,我们进行了组织化学和生物化学分析人胃癌组织中使用凝集素糖结合物的唾液酸化和肿瘤的临床病理特征之间的关系。我们在这里描述怀槐白细胞凝集素(MAL)阳性糖复合物只出现在胃肿瘤组织。另一方面,在非癌区域中未检测到染色。在淋巴结转移、淋巴管浸润、静脉浸润及进展期肿瘤中,MAL阳性表达率明显增高。预后分析显示,MAL阳性糖复合物的高表达与胃癌浸润深度、静脉浸润程度有关,是胃癌患者生存期缩短的独立因素,提示MAL阳性糖复合物存在于胃癌组织中,MAL检测的糖基化异常与胃癌的不良行为密切相关。因此,MAL可作为判断胃癌患者预后的有效工具。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TANG W, et al.: "Requirement of ceramide for adhesion of Helicobacter pylori to glycosphingolipids"FEBS Lett.. 504. 31-35 (2001)
TANG W 等:“幽门螺杆菌与鞘糖脂粘附所需的神经酰胺”FEBS Lett.. 504. 31-35 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
TANG W, Nakata M, Mafune K, Konishi T, 他5名, Makuuchi M: "Histochemical appearance and prognostic significance of Maackia amurensis leukoagglutinin-positive glycoconjugates in human gastric cancer"European Surgical Research. (in press).
TANG W、Nakata M、Mafune K、Konishi T 和其他 5 人,Makuuchi M:“人胃癌中山毛榉白细胞凝集素阳性结合物的组织化学表现和预后意义”欧洲外科研究(正在出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
TANG W, et al.: "Histochemical appearance and prognostic significance of Maackia amurensis leikoagglutinin-positive glycoconjugates in human gastric cancer(Proceedings of the 37th Congress of the European Society for Surgical Research)"Mihaly Boros Ed., M
TANG W, et al.:“人胃癌中猕猴桃凝集素阳性糖缀合物的组织化学表现和预后意义(欧洲外科研究学会第 37 届大会论文集)”Mihaly Boros Ed., M
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
TANG W, et al.: "Association of histochemical expression of Maackia amurensis leukoagglutinin-positive glycoconjugates with behaviour of human gastric cancer"Histopathology. 42. 239-245 (2003)
TANG W 等人:“山槐白细胞凝集素阳性糖缀合物的组织化学表达与人胃癌行为的关联”组织病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tang W, et al.: "Histochemical appearance and prognostic significance of Maackia amurensis leukoagglutinin-positive Glycoconjugates in human gastric cancer"Eur Surg Res. 34 (suppl 1). 72-73 (2002)
Tang W 等人:“人胃癌中猕猴桃白凝集素阳性糖缀合物的组织化学表现和预后意义”Eur Surg Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KARAKO Takashi其他文献

KARAKO Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KARAKO Takashi', 18)}}的其他基金

Development of novel molecular-targeted medicine against aminopeptidase
新型抗氨肽酶分子靶向药物的开发
  • 批准号:
    21390373
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Inhibition of intrahepatic metastasis of hepatocellularcarcinoma by novel pyrrolidine derivatives
新型吡咯烷衍生物抑制肝细胞癌肝内转移
  • 批准号:
    19591578
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CLINICAL SIGNIFICANCE OF CELLULAR EXPRESSION OF KL-6 MUCIN IN CHOLANGIOCRCINOMA
胆管癌中 KL-6 粘蛋白细胞表达的临床意义
  • 批准号:
    17591379
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ASSOCIATION OF GLYCOCONJUGATES EXPRESSION AND CLINICAL SIGNIFICANCE IN PATIENTS WITH METASTATIC CANCER OF THE LIVER
肝转移癌患者中糖缀合物表达及其临床意义的关联
  • 批准号:
    15591384
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Catalyst Project: Quantification of immunohistochemistry images of neuroglia
催化剂项目:神经胶质细胞免疫组织化学图像的量化
  • 批准号:
    2200489
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
Novel immunohistochemistry-based predictive and prognostic tests for hormone receptor-positive breast cancer
基于免疫组织化学的新型激素受体阳性乳腺癌预测和预后测试
  • 批准号:
    486311
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship Programs
Automated Staining Platform for Immunohistochemistry and In Situ Hybridization
用于免疫组织化学和原位杂交的自动化染色平台
  • 批准号:
    10177257
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
National Immunohistochemistry Standardization Program - Establishment & Launch
国家免疫组织化学标准化计划-建立
  • 批准号:
    10383397
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
VENTANA PD-L1 (SP142), a complimentary diagnostic immunohistochemistry (IHC) assay to ascertain tumor PD-L1 status for patients with metastatic urothelial cancer considering treatment with atezolizuma
VENTANA PD-L1 (SP142),一种免费的诊断性免疫组织化学 (IHC) 检测,用于确定考虑使用 atezolizuma 治疗的转移性尿路上皮癌患者的肿瘤 PD-L1 状态
  • 批准号:
    10273221
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Combining Multiplexed Immunohistochemistry and Deep Learning to Spatially Map the Tumour Microenvironment
结合多重免疫组织化学和深度学习来绘制肿瘤微环境的空间图
  • 批准号:
    449493
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship Programs
Comprehensive morphological analysis of cortical interneurons with three dimensional immunohistochemistry
三维免疫组化皮质中间神经元的综合形态学分析
  • 批准号:
    20K07231
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
3D molecular phenotyping of intact brain tissue via high-throughput active immunohistochemistry
通过高通量主动免疫组织化学对完整脑组织进行 3D 分子表型分析
  • 批准号:
    10266425
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
Statistical Methods For Quantitative Immunohistochemistry Biomarkers
定量免疫组织化学生物标志物的统计方法
  • 批准号:
    10331802
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
Statistical Methods For Quantitative Immunohistochemistry Biomarkers
定量免疫组织化学生物标志物的统计方法
  • 批准号:
    10083722
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了